Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer’s Disease | Center for Neurodegeneration and Translational Neuroscience (CNTN)

Frölich L, Atri A, Ballard C, Tariot PN, Molinuevo JL, Boneva N

J Alzheimer’s Dis

January 2019

← Back to Publications